HK1047116A1 - 來自mage的免疫原性肽及其應用 - Google Patents

來自mage的免疫原性肽及其應用

Info

Publication number
HK1047116A1
HK1047116A1 HK02108670.8A HK02108670A HK1047116A1 HK 1047116 A1 HK1047116 A1 HK 1047116A1 HK 02108670 A HK02108670 A HK 02108670A HK 1047116 A1 HK1047116 A1 HK 1047116A1
Authority
HK
Hong Kong
Prior art keywords
immunogenic peptides
immunogenic
peptides
Prior art date
Application number
HK02108670.8A
Other languages
English (en)
Inventor
C‧特拉福薩裡
S‧坦扎裡拉
C‧博迪格諾
Original Assignee
格內拉股份公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 格內拉股份公司 filed Critical 格內拉股份公司
Publication of HK1047116A1 publication Critical patent/HK1047116A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/027—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a retrovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HK02108670.8A 1999-05-21 2002-11-29 來自mage的免疫原性肽及其應用 HK1047116A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI001121A IT1312568B1 (it) 1999-05-21 1999-05-21 Peptidi immunogenici e loro uso.
PCT/EP2000/004465 WO2000071573A2 (en) 1999-05-21 2000-05-17 Immunogenic peptides derived from mage and the use thereof

Publications (1)

Publication Number Publication Date
HK1047116A1 true HK1047116A1 (zh) 2003-02-07

Family

ID=11383013

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02108670.8A HK1047116A1 (zh) 1999-05-21 2002-11-29 來自mage的免疫原性肽及其應用

Country Status (10)

Country Link
EP (1) EP1179019A2 (zh)
JP (1) JP2003502026A (zh)
KR (1) KR20020011418A (zh)
CN (1) CN1227264C (zh)
AU (1) AU777474B2 (zh)
CA (1) CA2374354A1 (zh)
HK (1) HK1047116A1 (zh)
IL (1) IL146605A0 (zh)
IT (1) IT1312568B1 (zh)
WO (1) WO2000071573A2 (zh)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235525B1 (en) * 1991-05-23 2001-05-22 Ludwig Institute For Cancer Research Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
US5662907A (en) * 1992-08-07 1997-09-02 Cytel Corporation Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes
US6291430B1 (en) * 1997-09-12 2001-09-18 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
US5965535A (en) * 1997-09-12 1999-10-12 Ludwig Institute For Cancer Research Mage-3 peptides presented by HLA class II molecules
ATE227302T1 (de) * 1998-10-29 2002-11-15 Dow Chemical Co Herstellung von titan(ii)- oder zirkon(ii)komplexe

Also Published As

Publication number Publication date
AU5067600A (en) 2000-12-12
ITMI991121A1 (it) 2000-11-21
IT1312568B1 (it) 2002-04-22
IL146605A0 (en) 2002-07-25
WO2000071573A2 (en) 2000-11-30
WO2000071573A3 (en) 2001-04-05
CA2374354A1 (en) 2000-11-30
CN1227264C (zh) 2005-11-16
JP2003502026A (ja) 2003-01-21
EP1179019A2 (en) 2002-02-13
AU777474B2 (en) 2004-10-21
KR20020011418A (ko) 2002-02-08
CN1360595A (zh) 2002-07-24

Similar Documents

Publication Publication Date Title
HRP20020375A2 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
HUP0202885A3 (en) Vaccines
IL148247A (en) Vaccine and its uses
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
GB9806806D0 (en) Peptides and uses thereof
AU2841801A (en) Triazolotriazinones and the use thereof
IL148953A0 (en) Novel hormonal composition and the use thereof
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
EG22491A (en) Rest-breaking composition and use thereof
HK1046925A1 (zh) Mage-a12抗原肽及其用途
EP1194548A4 (en) NOVEL PYRRHOCORICIN-DERIVED PEPTIDES AND METHODS OF IMPLEMENTING THE SAME
GB0026134D0 (en) Peptides and their use
EP1159288A4 (en) ALPHA-CONOTOXIN PEPTIDES
EP1241257A4 (en) TACHYKININ-SIMILAR POLYPEPTIDES AND ITS APPLICATION
GB9917165D0 (en) Polypeptides polynuclcotides and uses thereof
GB2380402B (en) Stretchers
GB0009204D0 (en) Headstones and the like
GB9903408D0 (en) Peptides
HK1047116A1 (zh) 來自mage的免疫原性肽及其應用
PL354184A1 (en) The prv-1 gene and use thereof
IL145527A0 (en) Retro-inverso prosaposin-derived peptides and use thereof
GB9929581D0 (en) Comjpositions and their use
GB9927353D0 (en) Virus preparation and use
HUP0201800A2 (en) Novel calpains and their use
EP1300416A4 (en) PEPTIDE FOR INCREASING THE MEMORY AND ITS APPLICATIONS